x min read

Worth Watching Stocks : J. C. Penney Company, Inc. (NYSE:JCP), Peabody Energy Corp. (NYSE:BTU), Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT), HCCI, Horizon Pharma plc (NASDAQ:HZNP)

Worth Watching Stocks : J. C. Penney Company, Inc. (NYSE:JCP), Peabody Energy Corp. (NYSE:BTU), Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT), HCCI, Horizon Pharma plc (NASDAQ:HZNP)
Written by
Charles Donlon
Published on
October 24, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

J C Penney Company Inc (NYSE:JCP) disclosed defeasance of its 6.875% Medium-Term Notes due in October next year. The company and its fully-owned subsidiary and the issuer of 6.875% Medium-Term Notes due in 2015, J C Penney Corporation, Inc., deposited nearly $63.85 million with Wilmington Trust. The notes were due in October next year. J. C. Penney Company, Inc. (NYSE:JCP) in last trading activity increased 3.20% to close at $7.73. Company weekly performance is 5.89% while its quarterly performance stands at -15.89%. J. C. Penney Company, Inc. (NYSE:JCP) is -31.59% away from its 52 week high. US-based Peabody Energy Corp, (NYSE:BTU) the world’s largest private pure play coal mining company by volume, reported a net loss of $US151 million in the last three months, taking year-to-date net loss to $US272 million. This follows a net loss of $US955 million in 2013 and a net loss of $US432 million in 2012. On last trading day Peabody Energy Corp. (NYSE:BTU) increased 1.16% to close at $10.43. Its volatility for the week is 7.48% while volatility for the month is 6.52%. BTU's sales growth for past 5 years was 1.30% and its EPS growth for past 5 years was -18.20%. Peabody Energy Corp. (NYSE:BTU) monthly performance is -18.00%. On October 16, Provectus Biopharmaceuticals Inc. (NYSEMKT:PVCT) a development-stage oncology and dermatology biopharmaceutical company (“Provectus”) announced today that Sanjiv S. Agarwala MD of St. Luke's University Hospital and Professor of Medicine at Temple University will present data on its investigational new drug PV-10 for the treatment of melanoma at the 11th International Congress of the Society for Melanoma Research in Zurich Switzerland. On last trading day Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) fell -4.08% to close at $0.94. Its volatility for the week is 5.73% while volatility for the month is 6.25%. PVCT's EPS growth for past 5 years was -1.90%. Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) monthly performance is -10.48%. Heritage-Crystal Clean Inc. (NASDAQ:HCCI) has bought the U.S. industrial waste and recycling services business of FCC for 70 million euro ($89.31 million). Elgin, Ill.-based Heritage acquired Houston-based FCC Environmental LLC’s U.S. operations, which have a strong focus on hydrocarbon-based waste streams. In 2013, FCC Environmental reported about $165.86 million in revenue, with about 500 employees. The operation serves more than 30,000 customers covering the eastern half of the country. Heritage-Crystal Clean, Inc (NASDAQ:HCCI) has 6.50% insider ownership while its institutional ownership stands at 46.40%. In last trading activity company's stock closed at $17.78. Horizon Pharma plc (NASDAQ:HZNP) announced that its third quarter 2014 financial results will be released on Thursday, November 6, 2014. On Thursday shares of Horizon Pharma plc (NASDAQ:HZNP) closed at $12.55. Company's EPS growth for next 5 years is recorded as 18.30%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You